Biofrontera Inc. Common Stock
Symbol: BFRI (NASDAQ)
1.01
▲ (0.93%) 0.009
Company Description:
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.
Key Stats
- Today's Open: $0.9829
- Today's High: $1.023
- Today's Low: $0.981
- Today's Volume: 83.35K
- Yesterday Close: $0.9967
- Yesterday High: $1.0299
- Yesterday Low: $0.98
- Yesterday Volume: 32.54K
- Last Min Volume: 100
- Last Min High: $1.006
- Last Min Low: $1.006
- Last Min VWAP: $1.006
Company Profile
- Name: Biofrontera Inc. Common Stock
- Website: https://www.biofrontera-us.com
- Listed Date: 2021-10-29
- Location: WOBURN, MA
- Market Status: Active
- CIK Number: 0001858685
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $10.63M
- Round Lot: 100
- Outstanding Shares: 10.67M
- Asset Type: CS
RECENT FILINGS FOR BFRI
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-30 | 3 | View |
| 2025-09-30 | 3 | View |
| 2025-09-30 | 3 | View |
| 2025-09-30 | 3 | View |
| 2025-09-26 | 3 | View |
| 2025-09-26 | 3 | View |
| 2025-09-25 | 3 | View |
| 2025-09-19 | 8-K | View |
| 2025-09-19 | SCHEDULE 13D/A | View |
| 2025-09-18 | 4 | View |
| 2025-09-16 | 4 | View |
| 2025-09-16 | 3 | View |
| 2025-09-16 | 4 | View |
| 2025-09-16 | 4 | View |
| 2025-09-16 | 4 | View |
| 2025-09-16 | 4 | View |
| 2025-09-16 | 4 | View |
| 2025-09-16 | 4 | View |
| 2025-08-19 | EFFECT | View |
| 2025-08-15 | CORRESP | View |
Latest News on BFRI